E xternal electrical cardioversion (EEC) was first performed in the 1950s. 1 This early experience demonstrated that electrical energy externally delivered to the thorax could stimulate the heart. In 1955, Zoll et al successfully terminated ventricular fib b brillation in a patient with externally applied defibrilb b lation shocks. Kouwenhoven and colleagues discovered that a batterybpowered direct current operated device could be fully portable. 2 Electrical countershocks can be delivered with either alternating current (AC) or direct current (DC) energy. Alternating currents are sinusoib b dal energy waveforms that switch between positive and negative polarity. The energy pulse lasts for approxib b mately 200 ms once discharged. Alternating current defibrillation can cause significant myocardial damage due to the greater energy flux and duration. 3 Urgent or elective DC cardioversions have specific advantages, such as termination of atrial and ventricular tachycardia and recovery of sinus rhythm.
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Mechanism of external cardioversion and defibrillat t tion
The current external electrical cardioversion technique relies on the application of a selected amount of enerb b gy, which is generally between 50b360 J, via two elecb b
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trodes (paddles). The mechanism of defibrillation is not known exactly. Zipes et al have suggested that failure to maintain the reentrant tachycardia by the remainb b ing myocardial tissue after depolarization of a critical mass is the main factor in the mechanism of electrical defibrillation. 4 Another research group has suggested that the shock waves of defibrillation prolong refracb b toriness in a sufficient mass of myocardial tissue and, consequently, terminate ventricular fibrillation (VF). 3 Whether the mechanisms suggested for the terminab b tion of VF are similar to those of atrial fibrillation (AF) remains unknown.
A lower limit of vulnerability also exists for the ventricular myocardium. This is the minimum voltage required by an electrical stimulus to induce fibrillation during the vulnerable period. It was also observed that the strengths of these shocks at ''the upper limit of vulb b nerability'' were approximately equivalent to the shocks at defibrillation threshold. The upper limit of vulnerab b bility hypothesis for defibrillation states that to defibrilb b late, a shock not only must halt the activation fronts of fibrillation, but it also must not reinitiate fibrillation by the same mechanism that a shock of the same strength during the vulnerable period of sinus or paced rhythm initiates fibrillation. 5
Indications

Atrial fibrilation and atrial flutter
Currently, electrical cardioversion is mostly performed to convert AF and atrial flutter into sinus rhythm. AF, encountered in intensive care units after cardiac surb b gery, is not suitable for electrical cardioversion since it is paroxysmal. In the treatment of recurrent AF atb b tacks, prevention of trigger mechanisms, application of specific antiarrhythmic therapies and improvement of electrolyte imbalance and hypoxia avert inappropriate cardioversion applications by blocking such episodes. AF treatment, on the other hand, includes anticoagub b lant therapy to minimize the risk of embolus and stroke during elective cardioversion. If AF persists for longer than 48 hours, anticoagulant therapy for 3 weeks is recommended with the international normalized ratio (INR) maintained >2.0. In case atrial activity is not achieved, therapy should be extended for 4 weeks, even after restoring sinus rhythm by electrical effective carb b dioversion. 6 A shorterblasting AF (<48 hours) can alb b ternatively be treated by heparinization and monitored by transesophageal echocardiography (TEE) prior to the cardioversion. 7 Any thrombotic formations within the left atrial appendix can be detected by TEE. The risk/benefit ratio should be assessed in all patients prib b or to cardioversion. Not observing a thrombus in TEE does not exclude the risk of embolus.
Venctricular and supraventricular tachycardia
Emergency electrical cardioversion is performed in unstable ventricular tachycardia that causes hemob b dynamic deterioration. If a patient with ventricular tachycardia is hemodynamically stable, sinus rhythm should be achieved by intravenous antiarrhythmics. Anticoagulation therapy is usually not necessary for cardioversion of ventricular tachycardia. Emergency electrical cardioversion is performed in unstable venb b tricular tachycardia that causes hemodynamic deteriob b ration. The aim of ventricular tachycardia treatment is the prompt termination of this impairment. Electrical cardioversion should be the next step in case of unsucb b cessful antiarrhythmic treatment and vagotonic mab b noeuvres such as carotid sinus massage for sustained supraventricular tachycardia. The success rate with cardioversion of ventricular tachycardia is generally around 95%. 8 
Other rhythm disorders
Electrical shock treatment is ineffective in the termib b nation of automaticity related tachycardies. Multifocal atrial tachycardias of this kind are generally confused with AF, which may lead to the inappropriate applicab b tion of direct current (DC) shocks. Since electrical carb b dioversion may cause resistant VF in patients with digib b talis toxicity, it is contraindicated in the presence of this condition. 8 Atrial flutter and ventricular tachycardia are tachycardias maintained by reentry circuits that may be terminated by local depolarization in the path of their circulating wavefronts. 8
Factors affecting EEC success
Energy is a combination of voltage and current. The overall success of the electrical cardioversion is related to the size of electrodes (paddles), application site, transthoracic impedance, and the applied current. For a given amount of energy, the amount of current reachb b ing the myocardium depends in part on the electrical impedance between the two defibrillator paddles. The distance between electrodes, electrodebskin interface and pressure (air is a poor conductor of electrical curb b rent), previous shocks (reduced impedance), time span between shocks (3bminute wait may cause resistance reduction), and physical characteristics (tall stature or increased BMI) decrease the rate of success. 9 The longb term success for AF is associated with the arrhythmia duration (>1 year) and the diameter of the enlarged left atrium (>5 cm). 8 Recurrence is more frequent in pab b tients with untreated hyperthyroidism, mitral stenosis or congestive heart failure. Successful cardioversion is dependent on certain factors, of which time might be the most important one. 10 Since myocardial adenosine increases the defibrillation threshold, which is depenb b dent on VF duration, its enhanced release may have a deleterious effect on defibrillation. 11 Another suggestion is that local changes in potassium concentration may increase defibrillation threshold. 12 If fibrillation time is prolonged in patients with AF, both postrepolarization and conduction delay occur due to global ischemia. 13 Energy is a combination of voltage and current.
Electrodes position
Defibrillator paddles can be used in different configub b rations, which affect the success rate of defibrillation. According to the International Liaison Committee on Resuscitation (ILCOR) guidelines, the sternal paddle should be placed 'just to the right of the upper sternal border below the clavicle and the apical paddle to the left of the nipple with the centre of the electrode in the midaxillary line. 14 Anteroposterior (parasternal and left infrascapular) positioning should be preferred for unsuccessful applications. It holds lower transthoracic impedance. By placing the paddles onto the chest wall, more current is delivered to the atria.
Thoracic impedance
Thoracic impedance is another important factor in treatb b ment by electrical cardioversion. The paddle area is the main determinant of transthoracic impedance. Current is inversely related to impedance. The optimal paddle size varies between 8 cm to12 cm. Air between the chest wall and the paddles prevents the effective conduction of the shock wave by increasing transthoracic impedb b ance. Any conductive material between paddles, such as gel or similar materials, increases conductance and deb b creases transthoracic impedance between the chest wall and the metal electrodes. Either special adhesive pads or special gels are used for this purpose. Contact beb b tween paddle area and chest wall must be provided. Gel between paddles should not touch in order to prevent current disorientation. 15 Such simple precautions cause a decrease in transthoracic impedance and increase the success of shock therapy. The resistance between elecb b trode and the skin enhances the efficacy of electrical carb b dioversion therapy by providing appropriate pressure on impedance paddles. Transthoracic impedance decreases if the pressure applied on the defibrillator paddles is increased, if appropriate contact between paddles and chest wall is provided, and expiration period is less reb b sistant compared to the inspiration. The shock wave is transmitted during the expirium period. 16
Electrode size
In pediatric patients ≤10 kg, pediatric paddles should be used for electrical cardioversion, with an applied pressure of 2.9 kgf. If the child is >10 kg, adultbtype paddles should be used, with an applied pressure of 5.1 kgf. 17 There are reports suggesting that chest shaving adds to the success of electrical cardioversion. 13 Sado et al stated that chest hair increased transthoracic impedb b ance, which could be reduced up to 35% by shaving. It is recommended to shave the chest hair of such patients prior to defibrillation. 18
Medications and sedations
In a pilot study, Sutton et al demonstrated that atropine administration increased the success rate of direct curb b rent cardioversion for atrial fibrillation. 19 Electrical carb b dioversion together with antiarrhythmics (such as amib b odarone) may help in the maintenance of sinus rhythm. It has been demonstrated that verapamil treatment prib b or to defibrillation may prevent recurrence of early AF by affecting atrial remodeling. 20 A recent study showed that shortbterm verapamil treatment associated with propafenone or amiodarone seems to be useless for the prevention of recurrent AF after low energy intracardib b ac cardioversion. 21 Quinidine and propafenone seem to be effective in preventing immediate reinitiation of AF. Ibutilide may prevent shock failure, although neither ibutilide nor dofetilide seems to be effective in preventb b ing immediate reinitiation of AF. 22 For refractory venb b tricular fibrillation or pulseless ventricular tachycardia, intravenous amiodarone 300 mg can be given initially, followed by a second dose of 150 mg. As an alternative, intravenous lidocaine 1b1.5 mg may be given, followed by 0.50b0.75 mg doses as needed up to a maximum of 3 mg. 23 Patients may feel pain even at low energy levels (1 J). Electrical cardioversion with high levels of energy should never be performed in conscious patients, since it may cause lifelong emotional disorders and psychob b logical trauma. 24 Administration of benzodiazepines, either alone or together with opiates, is not recomb b mended in patients who will undergo electrical cardiob b version. Propofol, an intravenous agent, seems to be an ideal drug for anesthesia since it acts rapidly, causes less laryngospasm, and loses its effect as soon as the treatb b ment is ceased. 25 For elective EEC, deep sedation or anb b esthesia is required in stable patients. Mild sedation is sufficient for less painful procedures. 26 
Energy selection
Biphasic shock and monophasic shock
Transthoracic monophasic defibrillators have been emb b ployed for the management of ventricular arrhythmias. European Resuscitation Council guidelines recommend a 200 J, 360 J sequence with subsequent shocks at 360 J if the arrhythmia is uncorrected. 14 Recent studies of ventricular fibrillation have confirmed the superiority of various biphasic waveforms over monophasic pulses of quivalent or similar duration. Biphasic waveforms offer equivalent or superior efficacy at lower energy and peak voltage than their monophasic counterparts. 27 Biphasic waveform shocks with a fixed energy of 150 J were as effective as conventional sequential monophasic waveb b form with progressive energy levels of 200, 300 and 360 J for successful defibrillation. However, the lowbenergy biphasic waveform shocks significantly decreased the severity of postresuscitation myocardial dysfunction. 28 An initial energy level for AF of 100b200J is recomb b mended. The success rate of electrical cardioversion is approximately 50%. In a recent study, an initial energy level of 360 J was suggested for persistent AF lastb b ing more than 48 hours. 29 In a study comparing 50 J with 100 J for the conversion of atrial flutter to sinus rhythm, 100 J was considered the best initial energy level. 30 Energy set between 100b200 J is recommended for monomorphic ventricular tachycardia, although lower energy levels may be effective as well. 31 On the other hand, the initial defibrillation threshold is sugb b gested to be 200 J in polymorphic ventricular tachyb b cardia or VF. The energy level should be 1b2 J/kg in children with ventricular tachycardia without a pulse or VF. 14 Low energy levels produce lesser myocardial damage and postbresuscitation myocardial dysfuncb b tion. 28 Synchronization with R wave is mandatory to prevent resistant VF that could be induced by shock wave and T wave overlapping, called a vulnerable peb b riod, if a QRS complex appeared during electrical carb b dioversion. Careful electrocardiographic (ECG) evalub b ation is required to avoid inappropriate shock therapies in patients with sinus or automatic tachycardia. Shock therapy should not be performed if only one derivation is being monitored in hemodynamically stable patients. Recurrent inappropriate and ineffective shock therapies can have dangerous consequences. Pharmacological prevention of atrial flutter recurrences is quite difficult. The typical recurrent atrial flutter should be treated by catheter ablation. The presence of a structural cardiac anomaly together with continuous ventricular tachycarb b dia or VF holds a risk for sudden death. An implantable cardioverter defibrillator (ICD) should be considered if there is no identifiable cause. Internal cardiac cardioverb b sion is safe and effective in patients with resistant AF. 32 A study comparing the efficacy of external and internal cardioversion in AF showed that internal cardioversion was more effective in restoring sinus rhythm. 33 Loss of QRS voltage after EEC or defibrillation was suggested to be of electrical origin or consequent to an edematous area on the chest wall due to trauma. Another proposed reason is myocardial stunning. 34
Management of patients with failed EEC or resistant patients
The risks and benefits of recurrent electrical shock therapy must be taken into account. Unnecessary reb b current DC shock treatment should be avoided. The upper shock limit applied by several defibrillators curb b rently used is 360 J, and the waveform is monophasic. As technology progresses, biphasic shock waves are employed. ICDs are the best example of such applicab b tion. The transvenous activity, the accessible implantab b tion, and the smaller dimensions have contributed to the wide therapeutic adoption of ICD devices. Lown mentioned that higher energy levels were required to terminate AF in congestive heart failure. Restoration of cardiac compensation and achievement of a dry weight before cardioversion increased the success rate. In casb b es of polycytemia, it may be difficult or impossible to revert until adequate phlebotomy lowers the hematob b crit to less than 50. Patients with severe mitral valve disease having giant scarred atria who have had valve repair or replacement are recalcitrant to cardioversion and do not persist in sinus rhythm. 31 The rate of sinus rhythm rebestablishment via internal cardioversion in AF, which is resistant to 360 J, varies between 70% and 80%. 35 The use of biphasic waves through multipolar catheters, which are placed within the right atrium and coronary sinus, enhances the success rate of cardioverb b sion by markedly reducing the required energy. Despite these low energy levels (2b3 J), sedation and anesthesia are necessary because of the painful procedure.
In new devices, the electrodes are placed within the right atrium and the left pulmonary artery for internal cardioversion. Superior homogeneous electrical disperb b sion and cardioversion effectiveness have been reported with such electrode placement. 9 In a multicenter study by Bardy et al, it was reported that automatic external defibrillators, which use biphasic wave shocks, required lower energy than those devices using monophasic waves. 36 A biphasic shock waveform is known to reb b duce the ventricular defibrilation testing. 37 Since synb b chronization with the R wave is not feasible for these devices, they are not applied in regular tachycardia with R waves.
Complications and contradictions of cardioversion
Complications are minimal. Potential complications inb b clude VF due to general anesthesia or lack of synchrob b nization between the DC shock and the QRS complex, thromboembolus due to insufficient anticoagulant therapy, nonbsustained VT, atrial arrhythmia, heart block, bradycardia, transient left bundle branch block, myocardial necrosis, myocardial dysfunction, transient hypotension, pulmonary edema and skin burn. Pain at the application site is associated with the number of apb b plications. 38 EEC is contraindicated in case of the presb b ence of left atrial thrombus and insufficient anesthesia in stable patients.
Special conditions
Arrhythmias in intensive care patients
Atrial and ventricular tachycardias are frequent in pab b tients being treated at intensive care units due to the presence of multiple triggers. Hypoxia, endogenous or exogenous catecholamines, congestive heart failure, fever and pulmonary embolus are particular causes of tachycardia. Patients unable to receive the drugs orally or with poor absorption are more prone to side effects, such as hypotension, which may especially occur with intravenous drugs like amiodarone. Rapid and throughb b out examination prior to the electrical cardioversion is important. Improvement of trigger and underlying etiologic factors enhances the success rate of cardioverb b sion. 8 It should be kept in mind that many consecutive shocks and anesthesia in recurrent doses may worsen hemodynamic status in those patients.
Internal cardiac cardioversion is safe and effective in patients with resistant AF. 34 A study comparing the efficacy of external and internal cardioversion in AF showed that internal cardioversion was more effective in restoring sinus rhythm. 35 
Cardioversion in Pregnancy
Some investigators have reported that electrical carb b dioversion is safe during pregnancy. 39 Cardioversion between 50 J and 300 J applied at various pregnancy phases revealed negligible effects on the fetus, which means harmful electrical current may not reach the fetus. 40,41 Almost 100 years ago, in his animal experib b ments, Garrey emphasized that a critical myocardial mass would be required for VF. For this reason, it can be assumed that cardioversion may not affect the feb b tus. 42 
EEC in patients with pacemakers
Electrical cardioversion performed in patients with a pacemaker or ICD may lead to dysfunction, namely acute or chronic changes in the pacing or sensitivb b ity threshold. 43 If a patient with a pacemaker should undergo cardioversion, the function and leads of the device should be checked, along with high voltage prob b gramming. Pacemaker mode should be switched to VOO or AOO if suitable. During cardioversion, the defibrillator paddles should be placed at a minimum of 15 cm apart from the pacemaker. They should be positioned perpendicularly to the anterolateral, anb b teroposterior or endocardial leads. A 5bminute interb b val between two shock wave applications is required. The pacemaker battery and lead functions must also be checked after cardioversion. A high threshold should be maintained for at least 4b6 weeks. In case of paceb b maker and lead dysfunction, lead replacement is the adb b vised procedure. 43 During cardioversion, patients with a pacemaker or ICD may be exposed to burns in the myocardial tissue where the pacemaker lead is attached if electrical current is delivered through it.
Conclusions
Cardioversion/defibrillation equipment is of the utb b most importance to clinicians. Electrical cardioversion is a lifebsaving when applied in emergency circumb b stances. In elective cardioversion, accurate tachycardia diagnosis, careful patient selection, adequate electrode (paddles) application, determination of the optimal energy and anesthesia levels, prevention of embolic events and arrythmia recurrence, and airway conservab b tion increase the success rate while minimizing possible complications. Although this procedure appears fairly simple, serious consequences might occur if inapprob b priately performed.
